Close navigation

What is a medulloblastoma?

Medulloblastomas are the most common high grade childhood brain tumour, accounting for 15-20% of all childhood brain tumours.

If your child or a child you know has recently been diagnosed with a medulloblastoma, you may be worried about what this means. This is a natural way to feel. Our Support and Information team can help answer any questions you may have or provide a listening ear if you need one.

What is a medulloblastoma?

Medulloblastomas are the most common central nervous system (CNS) embryonal tumour and account for 15-20% of all childhood brain tumours. 

They are:

  • fast growing
  • likely to spread to other areas of the brain or spinal cord.

Medulloblastomas usually develop in a part of the brain called the posterior fossa and are most commonly found in the cerebellum, an area of the posterior fossa that controls coordination and balance.

They are commonly found in children between the ages of 3 and 8, with a higher occurrence in males.

In the past few years, research has significantly advanced our understanding of medulloblastomas and we're now able to put them into 4 main groups based on demographic, clinical and genetic differences.

Unfortunately, a full genetic test to determine the type of medulloblastoma that your child may have is not yet routinely available on the NHS. However hospitals are developing the techniques to be able to do this in the near future.

WNT medulloblastoma

This is the best known subgroup of all the medulloblastomas and has been identified in 10-15% of patients. The average age of occurrence is 10 years old and it is more commonly found in females. 

These tumours often occupy the fourth ventricle; the fluid filled space in the middle of the posterior fossa.

SHH medulloblastoma

This type of medulloblastoma frequently occurs in both infants (under three) and adults (over 16), but are less frequent in children aged three to sixteen. 

SHH medulloblastoma is commonly associated with a condition known as Gorlin syndrome, due to a gene mutation that causes the over-activation of cells, leading to the formation of a tumour.

Group 3 medulloblastoma

This type of medulloblastoma occurs more commonly in males than females, and are most common in young children ranging from one to ten years old. 

At diagnosis, these are often metastatic (already spread to other parts of the brain and spinal cord). Similar to the WNT medulloblastomas, the tumour is generally located within the fourth ventricle.

Group 4 medulloblastoma

This is the most common subgroup of medulloblastoma, making up around 35-40% of all cases. These tumours can occur in all ages but are most prevalent in mid-childhood.

Track how your child feels

If your child is diagnosed with a medulloblastoma, it can be overwhelming. Use BRIAN’s quality-of-life tracker to monitor how they feel and the symptoms they have. Then share this with their healthcare team to show what they most need support with.

BRIAN QOL tracker

BRIAN is our trusted online app where you can track your experience, compare it with others who’ve been there and get the knowledge you need to make informed decisions.

Find out more

What are the symptoms of a medulloblastoma?

As well as the symptoms common across many childhood brain tumours, the location of a medulloblastoma is likely to cause increased pressure in the skull. The symptoms of a medulloblastoma will therefore likely include:

  • abrupt onset of headaches, especially in the morning
  • nausea and/or vomiting
  • feeling extremely tired
  • loss of balance and co-ordination which may lead to difficulty walking
  • abnormal eye movements
  • blurry vision caused by swelling of the optic disc at the back of the eye (papilloedema).

In some cases, the tumour can spread to the spinal cord, causing another set of symptoms, such as back pain, an inability to control the bowels and bladder and difficulty walking.

Find out more

Back to the top

How are medulloblastomas treated?

Treatment for medulloblastoma is likely to include a combination of surgery, radiotherapy and chemotherapy.

The first course of treatment is usually neurosurgery to remove the tumour. However, if your child's tumour has caused a build-up of CSF, the surgeon may first need to perform an operation to reduce the pressure. 

Following surgery, radiotherapy is often used to destroy any remaining tumour cells. It is normally given to the whole brain and spinal cord as medulloblastomas can travel through the CSF to the spinal cord. 

If a child is aged under 3, whole brain radiotherapy is usually avoided and high-dose chemotherapy may be used to delay or eliminate the need for radiotherapy. 

In some cases, children older than 3 may be given several cycles of high-dose chemotherapy before or after radiotherapy.

Find out more

Back to the top

What causes medulloblastomas?

It’s important to understand that nothing you've done or could have avoiding doing would have prevented a brain tumour from developing.  

As with all brain tumours, we don't know for sure what causes medullblastomas to start growing, although we do understand some of the risk factors involved.

SHH medulloblastomas in particular are commonly associated with a condition known as Gorlin syndrome, due to a gene mutation that causes the over-activation of cells, leading to the formation of a tumour.

Back to the top

How long can somebody live with a medulloblastoma?

There is no way to know for certain. While averages can be given, everybody is different – it will depend on so many factors – not only your tumour grade, size and location, but also your general health, your individual body chemistry, and how you respond to treatment.

Medulloblastoma prognosis

Back to the top

Get support

If you need someone to talk to or advice on where to get help, our Support and Information team is available by phone, email or live-chat.

About brain tumours

Our animation can help children to understand a brain tumour diagnosis.

Dr Gajjar discusses embryonal tumours, including Medulloblastoma, PNET and ATRT and NPID, National Paediatric Information Day, 2016.

If you have further questions, need to clarify any of the information on this page, or want to find out more about research and clinical trials, please contact our team:

Information and Support line

0808 800 0004 (free from landlines and mobiles)

support@thebraintumourcharity.org

Phone lines open Mon-Fri, 09:00-17:00

You can also join our active online community on Facebook - find out more about our groups.